EMA Perspective/Clinical Trials & Frailty

Watch the webinar
Dr. Francesca Cerreta’s presentation
Cynthia Ben’s presentation

AIM Banner EMA Perspective_final

On April 21, the AIM Coalition held a webinar on frailty with featured speaker Francesca Cerreta, senior scientific officer, ‎European Medicines Agency (EMA).

In December of 2015, the EMA released a draft working paper titled “Points to consider on frailty: Evaluation instruments for baseline characteristics of clinical trial populations.” Among other considerations, this working paper includes the short physical performance battery (SPPB) and gait speed as measures of possible use in identifying vulnerable populations at risk of adverse outcomes. This webinar will feature an overview of the working paper as well as the EMA geriatric strategy.

To see AIM’s previous webinar titled “Stakeholder Perspectives on Sarcopenia Patient-Reported Outcome Measures,” go here.